Clinical Trial Update: Lipoprotein and Apolipoproteins With Metabolic Liver Diseases

View source ↗

Summary

A clinical trial update on lipoprotein and apolipoprotein involvement in metabolic liver diseases; the current status of the trial is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorders of Lipoprotein Metabolism

Snippet

Sponsor: Chun-Hsiang Wang | Conditions: Disorders of Lipoprotein Metabolism and Other Lipidaemias | Status: UNKNOWN